Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
INPP5B antisense RNA 1 (INPP5B-AS1) is a long non-coding RNA affiliated with the lncRNA class. It is transcribed from the antisense strand relative to the INPP5B gene locus. Although diseases such as vitreoretinopathy have been associated with this gene, its precise biological function and potential mechanism of involvement in disease processes are not yet established. It is not a protein-coding gene, does not function as a receptor, enzyme, or classic therapeutic target, and there are no known interacting drugs or biomarker roles documented at this time.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on INPP5B antisense RNA 1 (INPP5B-AS1).